Drug Database
V03 ALL OTHER THERAPEUTIC PRODUCTS
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- V03AB Antidotes
- V03AB03 edetates
- V03AB08 sodium nitrite
- V03AB14 protamine
- V03AB15 naloxone
- V03AB17 methylthioninium chloride
- V03AB21 potassium iodide
- V03AB23 acetylcysteine
- V03AB24 digitalis antitoxin
- V03AB25 flumazenil
- V03AB33 hydroxocobalamin
- V03AB35 sugammadex
- V03AB37 idarucizumab
- V03AB38 andexanet alfa
- V03AC01 deferoxamine
- V03AC02 deferiprone
- V03AC03 deferasirox
- V03AE01 polystyrene sulfonate
- V03AE02 sevelamer
- V03AE03 lanthanum carbonate
- V03AE04 calcium acetate and magnesium carbonate
- V03AE05 sucroferric oxyhydroxide
- V03AE07 calcium acetate
- V03AE09 patiromer calcium
- V03AE10 sodium zirconium cyclosilicate
- V03AF01 mesna
- V03AF02 dexrazoxane
- V03AF03 calcium folinate
- V03AF04 calcium levofolinate
- V03AF06 sodium folinate
- V03AF07 rasburicase
- V03AF10 sodium levofolinate
- V03AF11 arginine and lysine
- V03AH01 diazoxide
- V03AK Tissue adhesives
- V03AX Other therapeutic products
- V03AX03 cobicistat
- V03AX04 difelikefalin
- V03AZ01 ethanol
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).